The great buildout for AI and GLP-1 drugs continues. (00:21) Jason Moser and Matt Argersinger discuss:- How Nvidia continues to deliver in the face of great expectations, but even those great results haven’t kept the market happy with the chipmaker or big tech stocks to start 2025.- Apple and Eli Lilly’s plans to expand manufacturing and development in the U.S.- Earning updates from Home Depot, Axon, and Cava. Here is Jason’s fabled at-home Cava recipe: https://moribyan.com/spicy-lamb-meatballs-cava-copycat/ (19:11) Jason dives deeper into Axon’s earnings with President Josh Isner, breaking down some of the major growth opportunities ahead, and how the company is approaching the focus on government budgets and tariff talks.(34:53) Matt and Jason break down two stocks on their radar: Marqueta and EPR Properties.Stocks discussed: NVDA, AAPL, LLY, HD, AXON, CAVA, MQ, EPRHost: Dylan LewisGuests: Jason Moser, Matt Argersinger, Josh IsnerEngineers: Dan Boyd, Rick Engdahl Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Nvidia, Apple, and Eli Lilly: Manufacturing the Future

Motley Fool Money

AI Chapters

AI Insights

Reviews